Balance Sheet

v3.24.1.u1

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 4,455	$ 3,173
Restricted cash		6,300
Accounts receivable, net	4,354	6,744
Inventories, net	6,611	10,257
Prepaid expenses and other current assets	812	1,051
Total Current Assets	16,232	27,525
Fixed assets, net	230	375
Right-of-use assets, operating leases	120	173
Intangible assets, net		10,059
Other assets	155	544
Total Assets	16,737	38,676
Current Liabilities
Accounts payable	6,928	2,932
Accrued and other liabilities	2,085	2,596
Line of credit	1,741
Term loan, net	2,881
Operating lease liability	57	52
Total Current Liabilities	13,692	5,580
Non-current Liabilities
Line of credit, net		11,444
Operating lease liability	67	124
Total Non-current Liabilities	67	11,568
Total Liabilities	13,759	17,148
Stockholders’ Equity
Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023 and 2022, respectively	32	29
Additional paid-in capital	324,288	320,071
Accumulated deficit	(321,342)	(298,572)
Total Stockholders’ Equity	2,978	21,528
Total Liabilities and Stockholders’ Equity	$ 16,737	$ 38,676

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source